News and Analysis

Interius BioTherapeutics nabs $76m Series A

Interius BioTherapeutics, a preclinical stage gene therapy company, has raised $76 million in Series A financing.

-

Interius BioTherapeutics, a preclinical stage gene therapy company, has raised $76 million in Series A financing. Cormorant Asset Management and Fairmount Funds led the round.

Source: Press Release